Experiences of cancer survivors in Europe: has anything changed? Can artificial intelligence offer a solution?

Iman Hesso; Reem Kayyali; Andreas Charalambous; Maria Lavdaniti; Evangelia Stalika; Maria Lelegianni; Shereen Nabhani-Gebara

doi:10.3389/fonc.2022.888938

Experiences of cancer survivors in Europe: has anything changed? Can artificial intelligence offer a solution?

Iman Hesso
, Reem Kayyali
, Andreas Charalambous
, Maria Lavdaniti
, Evangelia Stalika
, Maria Lelegianni
, Shereen Nabhani-Gebara

Research output: Contribution to journal › Article › peer-review

1 Downloads (Pure)

Original language	English
Article number	888938
Journal	Frontiers in Oncology
Volume	12
Early online date	14 Sept 2022
DOIs	https://doi.org/10.3389/fonc.2022.888938
Publication status	Published - 14 Sept 2022

Bibliographical note

Note: This work was supported by the European commission under the European Union's Horizon 2020 research and innovation programme under grant agreement No.952179.

Keywords

Cancer studies

Access to Document

10.3389/fonc.2022.888938

Hesso-I-52184-VoRFinal published version, 492 KBLicence: CC BY

https://doi.org/10.3389/fonc.2022.888938

Cite this

@article{0e6852dc89a949f7b09399486cf63a73,

title = "Experiences of cancer survivors in Europe: has anything changed? Can artificial intelligence offer a solution?",

keywords = "Cancer studies",

author = "Iman Hesso and Reem Kayyali and Andreas Charalambous and Maria Lavdaniti and Evangelia Stalika and Maria Lelegianni and Shereen Nabhani-Gebara",

note = "Note: This work was supported by the European commission under the European Union's Horizon 2020 research and innovation programme under grant agreement No.952179.",

year = "2022",

month = sep,

day = "14",

doi = "10.3389/fonc.2022.888938",

language = "English",

volume = "12",

journal = "Frontiers in Oncology",

issn = "2234-943X",

publisher = "Frontiers Media SA",

}

TY - JOUR

T1 - Experiences of cancer survivors in Europe

T2 - has anything changed? Can artificial intelligence offer a solution?

AU - Hesso, Iman

AU - Kayyali, Reem

AU - Charalambous, Andreas

AU - Lavdaniti, Maria

AU - Stalika, Evangelia

AU - Lelegianni, Maria

AU - Nabhani-Gebara, Shereen

N1 - Note: This work was supported by the European commission under the European Union's Horizon 2020 research and innovation programme under grant agreement No.952179.

PY - 2022/9/14

Y1 - 2022/9/14

KW - Cancer studies

U2 - 10.3389/fonc.2022.888938

DO - 10.3389/fonc.2022.888938

M3 - Article

SN - 2234-943X

VL - 12

JO - Frontiers in Oncology

JF - Frontiers in Oncology

M1 - 888938

ER -